Health ❯Diseases ❯Neurological Disorders ❯Alzheimer's Disease

Donanemab

FDA Approves Donanemab: A Breakthrough in Early Alzheimer’s Treatment

FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab